Arrhythmogenic cardiomyopathy

From WikiMD.org
Jump to navigation Jump to search

Arrhythmogenic Cardiomyopathy (pronunciation: a-rith-mo-genic car-dio-my-op-a-thy) is a rare, genetic cardiomyopathy that affects the heart and can lead to sudden cardiac death, especially in young people and athletes.

Etymology

The term "Arrhythmogenic Cardiomyopathy" is derived from three Greek words: "arrhythmia" meaning without rhythm, "cardio" meaning heart, and "myopathy" meaning disease of the muscle.

Definition

Arrhythmogenic Cardiomyopathy (AC) is a genetic disorder characterized by the replacement of myocardial tissue with fibro-fatty tissue. This process leads to irregular heart rhythms or arrhythmias and can result in sudden cardiac death.

Symptoms

Symptoms of Arrhythmogenic Cardiomyopathy can include palpitations, fainting, and shortness of breath. However, some individuals with AC may not exhibit any symptoms until sudden cardiac death occurs.

Diagnosis

Diagnosis of Arrhythmogenic Cardiomyopathy is often made through a combination of ECG, ECHO, and MRI tests. Genetic testing can also be used to identify the presence of mutations associated with AC.

Treatment

Treatment for Arrhythmogenic Cardiomyopathy typically involves managing symptoms and reducing the risk of sudden cardiac death. This can include medication, lifestyle changes, and in some cases, the implantation of a ICD.

Related Terms

External links

Esculaap.svg

This WikiMD article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski